Rigel Pharmaceuticals, Inc.

Direct answer

Rigel Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker RIGL.

Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; REZLIDHIA, a non-intensive monotherapy to treat adult patients with relapsed or refractory...

Can you invest in Rigel Pharmaceuticals, Inc.?

Yes. Rigel Pharmaceuticals, Inc. trades publicly on NASDAQ as RIGL.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Rigel Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.